All In Biotech

Drug Trial Radar · NCT02472769

IBP-9414 for the Prevention of Necrotizing Enterocolitis

A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.

Last checked: Nov 20, 2026Latest source record: Dec 29, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

May 27, 2016

Primary completion

Aug 7, 2017

Study completion Aug 7, 2017

Sponsor

Lead sponsor
Infant Bacterial TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 16, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, up to 48 hours
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Two different dose levels will be evaluated in two different birth weight categories, compared to placebo with regards to safety and tolerability.

Conditions

  • Necrotizing Enterocolitis

Interventions

  • IBP-9414Drug

  • PlaceboDrug

    Sterile water

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Tolerability of IBP-9414 as the observed number of adverse events (AE) and serious adverse events (SAE)Time frame: 12 months

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Univ. Arkansas Medical Sciences

    Little Rock, Arkansas

  • UCLA Medical Center

    Los Angeles, California

  • University Florida Health

    Gainesville, Florida

  • Wolfson Children´s Hospital

    Jacksonville, Florida

  • UF Health Jacksonville

    Jacksonville, Florida

  • Jackson Memorial Hospital

    Miami, Florida

  • Memorial Hospital of South Bend

    South Bend, Indiana

  • Wesley Medical Center

    Wichita, Kansas

  • Kings County Hospital Center

    Brooklyn, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina

  • Hahnemann University Hospital

    Philadelphia, Pennsylvania

  • Einstein Medical Center of Philadelphia

    Philadelphia, Pennsylvania

  • Jackson Madison County General Hospital

    Jackson, Tennessee

  • Timpanogos Regional Hospital

    Orem, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.